This compound is primarily utilized in neuroscience research as a selective antagonist for metabotropic glutamate receptors (mGluRs), specifically targeting the mGluR1 subtype. It is employed to study the role of these receptors in synaptic transmission, plasticity, and neuronal signaling pathways. Its application extends to investigating neurological disorders such as epilepsy, Parkinson's disease, and chronic pain, where mGluR1 dysfunction is implicated. Additionally, it is used in pharmacological experiments to understand the mechanisms of glutamate-mediated excitotoxicity and to develop potential therapeutic strategies targeting glutamate receptors.